Quick Answer
MEDIFAST INC reported Operating Income Loss of -$14.21 million for the year ending 2025.
- MEDIFAST INC showed a decrease of -593.8% in Operating Income Loss from 2024 to 2025.
- This data is from MEDIFAST INC's annual report (Form 10-K), filed with the SEC on February 17, 2026.
- XBRL data for this metric is available from 2009 to 2025 (17 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2010: $9.26 million | Q3 2010: $9.05 million | Q1 2011: $10.10 million | Q2 2011: $9.06 million | Q3 2011: $6.71 million | Q1 2012: $6.14 million | Q2 2012: $4.60 million | Q3 2012: $8.93 million | Q1 2013: $8.58 million | Q2 2013: $10.64 million | Q3 2013: $7.35 million | Q1 2014: $9.61 million | Q2 2014: $9.86 million | Q3 2014: $6.59 million | Q1 2015: $6.51 million | Q2 2015: $8.66 million | Q3 2015: $7.98 million | Q1 2016: $6.27 million | Q2 2016: $5.02 million | Q3 2016: $8.95 million | Q1 2017: $8.61 million | Q2 2017: $11.31 million | Q3 2017: $10.23 million | Q1 2018: $14.68 million | Q2 2018: $17.11 million | Q3 2018: $17.47 million | Q1 2019: $24.72 million | Q2 2019: $27.36 million | Q3 2019: $20.26 million | Q1 2020: $23.53 million | Q2 2020: $28.10 million | Q3 2020: $44.56 million | Q1 2021: $52.80 million | Q2 2021: $61.43 million | Q3 2021: $55.17 million | Q1 2022: $55.09 million | Q2 2022: $48.96 million | Q3 2022: $48.16 million | Q1 2023: $53.51 million | Q2 2023: $38.71 million | Q3 2023: $25.51 million | Q1 2024: $7.94 million | Q2 2024: -$7.88 million | Q3 2024: $2.11 million | Q1 2025: -$1.26 million | Q2 2025: -$1.07 million | Q3 2025: -$4.08 million.
- Over the full 17 years of available data (2009 to 2025), MEDIFAST INC's Operating Income Loss has declined by 176.8%.
- Historical annual values: Fiscal year 2025: -$14.21 million | Fiscal year 2024: $2.88 million | Fiscal year 2023: $126.40 million | Fiscal year 2022: $184.81 million | Fiscal year 2021: $216.24 million | Fiscal year 2020: $134.16 million | Fiscal year 2019: $91.04 million | Fiscal year 2018: $69.06 million | Fiscal year 2017: $39.63 million | Fiscal year 2016: $26.86 million | Fiscal year 2015: $28.68 million | Fiscal year 2014: $30.25 million | Fiscal year 2013: $38.41 million | Fiscal year 2012: $27.14 million | Fiscal year 2011: $27.38 million | Fiscal year 2010: $31.64 million | Fiscal year 2009: $18.50 million.
- Data sourced from SEC EDGAR public filings as of August 8, 2026.
Last verified: